Yvonne Greenstreet

Insider profile

Currently holds positions in Alnylam Pharmaceuticals Inc and Pacira Biosciences Inc

Performance

Overall performance
3.5

Performance over holding periods
3.5
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
123 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Operating Officer Alnylam Pharmaceuticals Inc Jan. 1, 2018 -
Independent Director Pacira Biosciences Inc March 4, 2014 -
Independent Director Moelis & Co Feb. 19, 2015 - Dec. 31, 2018
Chief Operating Officer, Executive Vice President Alnylam Pharmaceuticals Inc Sept. 19, 2016 - Jan. 1, 2018

Yvonne Greenstreet's trades of Alnylam Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-06 2026-03-04 S Sale
48,560 +21.0%
83.74
US$1,960,327
48,560 +21.0% 83.74 US$1,960,327
2026-03-06 2026-03-04 S Sale
94,275 -10.9%
224.09
US$4,859,631
94,275 -10.9% 224.09 US$4,859,631
2026-03-06 2026-03-04 S Sale
78,538 +32.3%
27.08
US$2,419,400
78,538 +32.3% 27.08 US$2,419,400
2026-03-06 2026-03-04 S Sale
444 -0.5%
323.01
US$143,416
444 -0.5% 323.01 US$143,416
2026-03-06 2026-03-04 S Sale
368 -0.4%
321.82
US$118,430
368 -0.4% 321.82 US$118,430
2026-03-06 2026-03-04 S Sale
274 -0.3%
320.81
US$87,902
274 -0.3% 320.81 US$87,902
2026-03-06 2026-03-04 S Sale
129 -0.1%
320.01
US$41,281
129 -0.1% 320.01 US$41,281
2026-03-06 2026-03-04 S Sale
135 -0.1%
319.03
US$43,069
135 -0.1% 319.03 US$43,069
2026-03-04 2026-03-02 S Sale
160 -0.2%
332.64
US$53,222
160 -0.2% 332.64 US$53,222
2026-03-04 2026-03-02 S Sale
399 -0.4%
331.93
US$132,440
399 -0.4% 331.93 US$132,440
2026-03-04 2026-03-02 S Sale
346 -0.3%
330.85
US$114,474
346 -0.3% 330.85 US$114,474
2026-03-04 2026-03-02 S Sale
722 -0.7%
329.71
US$238,051
722 -0.7% 329.71 US$238,051
2026-03-04 2026-03-02 S Sale
424 -0.4%
328.71
US$139,373
424 -0.4% 328.71 US$139,373
2026-03-04 2026-03-02 S Sale
1,399 -1.4%
327.67
US$458,410
1,399 -1.4% 327.67 US$458,410
2026-03-04 2026-03-02 S Sale
1,669 -1.6%
326.81
US$545,446
1,669 -1.6% 326.81 US$545,446
2026-03-04 2026-03-02 S Sale
1,098 -1.0%
325.63
US$357,542
1,098 -1.0% 325.63 US$357,542
2026-03-04 2026-03-02 S Sale
382 -0.4%
324.65
US$124,016
382 -0.4% 324.65 US$124,016
2026-03-04 2026-03-02 S Sale
200 -0.2%
323.62
US$64,724
200 -0.2% 323.62 US$64,724
2026-02-17 2026-02-13 S Sale
6,958 -7.5%
310.08
US$2,157,542
6,958 -7.5% 310.08 US$2,157,542
2026-01-14 2026-01-12 S Sale
94 -0.1%
377.82
US$35,515
94 -0.1% 377.82 US$35,515
2026-01-14 2026-01-12 S Sale
118 -0.2%
375.65
US$44,327
118 -0.2% 375.65 US$44,327
2026-01-14 2026-01-12 S Sale
88 -0.1%
374.44
US$32,951
88 -0.1% 374.44 US$32,951
2026-01-14 2026-01-12 S Sale
21 -0.0%
372.46
US$7,822
21 -0.0% 372.46 US$7,822
2026-01-14 2026-01-12 S Sale
118 -0.1%
370.87
US$43,763
118 -0.1% 370.87 US$43,763
2026-01-14 2026-01-12 S Sale
253 -0.3%
369.48
US$93,478
253 -0.3% 369.48 US$93,478
2026-01-14 2026-01-12 S Sale
584 -0.7%
368.62
US$215,274
584 -0.7% 368.62 US$215,274
2026-01-14 2026-01-12 S Sale
261 -0.3%
367.40
US$95,891
261 -0.3% 367.40 US$95,891
2026-01-14 2026-01-12 S Sale
316 -0.4%
366.41
US$115,786
316 -0.4% 366.41 US$115,786
2026-01-14 2026-01-12 S Sale
1,395 -1.7%
365.56
US$509,956
1,395 -1.7% 365.56 US$509,956
2026-01-14 2026-01-12 S Sale
1,259 -1.5%
364.83
US$459,321
1,259 -1.5% 364.83 US$459,321
2026-01-14 2026-01-12 S Sale
301 -0.4%
363.55
US$109,429
301 -0.4% 363.55 US$109,429
2026-01-14 2026-01-12 S Sale
464 -0.6%
362.38
US$168,144
464 -0.6% 362.38 US$168,144
2026-01-14 2026-01-12 S Sale
624 -0.7%
361.45
US$225,545
624 -0.7% 361.45 US$225,545
2026-01-14 2026-01-12 S Sale
980 -1.1%
360.22
US$353,016
980 -1.1% 360.22 US$353,016
2026-01-14 2026-01-12 S Sale
537 -0.6%
359.14
US$192,858
537 -0.6% 359.14 US$192,858
2026-01-14 2026-01-12 S Sale
778 -0.9%
358.18
US$278,664
778 -0.9% 358.18 US$278,664
2026-01-14 2026-01-12 S Sale
607 -0.7%
357.17
US$216,802
607 -0.7% 357.17 US$216,802
2026-01-14 2026-01-12 S Sale
263 -0.3%
356.09
US$93,652
263 -0.3% 356.09 US$93,652
2026-01-14 2026-01-12 S Sale
269 -0.3%
355.16
US$95,538
269 -0.3% 355.16 US$95,538
2026-01-14 2026-01-12 S Sale
247 -0.3%
353.95
US$87,426
247 -0.3% 353.95 US$87,426
2025-11-14 2025-11-13 PlS Planned sale
261 -0.4%
456.03
US$119,024
261 -0.4% 456.03 US$119,024
2025-11-14 2025-11-13 PlS Planned sale
195 -0.3%
454.69
US$88,665
195 -0.3% 454.69 US$88,665
2025-11-14 2025-11-13 PlS Planned sale
881 -1.3%
453.99
US$399,965
881 -1.3% 453.99 US$399,965
2025-11-14 2025-11-13 PlS Planned sale
1,599 -2.3%
452.85
US$724,107
1,599 -2.3% 452.85 US$724,107
2025-11-14 2025-11-13 PlS Planned sale
1,702 -2.4%
451.94
US$769,202
1,702 -2.4% 451.94 US$769,202